ZIRCLERIX Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for ZIRCLERIX with the United States Patent and Trademark Office. The USPTO has given the ZIRCLERIX trademark a serial number of 79400837. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 1, 2025. This trademark is owned by Telix Pharmaceuticals Limited. The ZIRCLERIX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use
zirclerix

General Information


Serial Number79400837
Word MarkZIRCLERIX
Filing DateFriday, March 8, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 22, 2025

Trademark Statements


Goods and ServicesChemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer
Goods and ServicesMedical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 25, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, July 25, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, July 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 30, 2024APPLICATION FILING RECEIPT MAILED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Sunday, September 22, 2024NON-FINAL ACTION WRITTEN
Monday, September 23, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 23, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 23, 2024REFUSAL PROCESSED BY MPU
Monday, March 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 12, 2024REFUSAL PROCESSED BY IB